FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

21976811000001105: Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Mar 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2120701000001119 Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2120721000001114 Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Is a Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has specific active ingredient Azelastine hydrochloride true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has excipient Benzalkonium chloride false Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Is a Dymista true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has active ingredient Azelastine true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has active ingredient Fluticasone true Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 120 dose Has AMP True Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start